GeneChips in Regenerative Medicine

Principles of Regenerative Medicine

Volumn , Issue , 2008, Pages 562-578

  Hipp, Jason ^a   Atala, Anthony ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84882904504     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-012369410-2.50034-6     Document Type: Chapter

References (54)

1. Abbot T.M., Hermann W.J., Scully R.E. Ovarian fetiform teratoma (homunculus) in a 9-year-old girl. Int. J. Gynecol. Pathol. 1984, 2(4):392-402.
2. Abeyta M.J. Unique gene expression signatures of independently-derived human embryonic stem cell lines. Hum.Mol. Genet. 2004, 13(6):601-608.
3. Affymetrix Microarray Suite User Guide 2001, Ref Type: Generic.
4. Affymetrix GeneChip Expression Analysis Technical Manual 2004, 9-12-2004. Ref Type: Generic.
5. Affymetrix Statistical algorithms description document 2005, Technical Report. Ref Type: Generic.
6. Al-Hajj M. Therapeutic implications of cancer stem cells. Curr. Opin. Genet. Dev. 2004, 14(1):43-47.
7. Andrews P.W. Teratocarcinomas and human embryology: pluripotent human EC cell lines. Acta Pathologica, Microbiologica et Immunologica Scandinavica 1998, 106(1):158-167.
8. Ashburner M. Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat. Genet. 2000, 25(1):25-29.
9. Ball C.A. The Stanford Microarray Database accommodates additional microarray platforms and data formats. Nucleic Acids Res. 2005, 33(Database issue):D580-D582.
10. Barrett T. NCBI GEO: mining millions of expression profiles - database and tools. Nucleic Acids Res. 2005, 33:D562-D566. Database issue.
11. Benjamini Y., Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. Roy. Stat. Soc. B 1995, 57:289-300.
12. Bolstad B.M. affyPLM The Threestep Function 2005, 5-18-2005 Ref Type: Generic.
13. Bolstad B.M. affyPLM: Fitting Probe Level Models, Document 2005, 5-18-2005. Ref Type: Generic.
14. Bolstad B.M. A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics 2003, 19(2):185-193.
15. Bolstad B.M. Experimental design and low-level analysis of microarray data. Int. Rev. Neurobiol. 2004, 60:25-58.
16. Brivanlou A.H. Stem cells. Setting standards for human embryonic stem cells. Science 2003, 300(5621):913-916.
17. Chen J. The PEPR GeneChip data warehouse, and implementation of a dynamic time series query tool (SGQT) with graphical interface. Nucleic Acids Res. 2004, 32(Database issue):D578-D581.
18. Cibelli J.B. Parthenogenetic stem cells in nonhuman primates. Science 2002, 295(5556):819.
19. Cobleigh M.A. Multinational study of the efficacy and safety of humanized anti-HER2 monoclonal antibody in women who have HER2-overexpressing metastatic breast cancer that. J. Clin. Oncol. 1999, 17(9):2639-2648.
20. Cope L.M. A benchmark for Affymetrix GeneChip expression measures. Bioinformatics 2004, 20(3):323-331.
21. Cowan C.A. Nuclear reprogramming of somatic cells after fusion with human embryonic stem cells. Science 2005, 309(5739):1369-1373.
22. Dahlquist K.D. GenMAPP, a new tool for viewing and analyzing microarray data on biological pathways. Nat. Genet. 2002, 31(1):19-20.
23. Dennis G. DAVID: database for annotation, visualization, and integrated discovery. Genome Biol. 2003, 4(5):3.
24. Doniger S.W. MAPPFinder: using gene ontology and GenMAPP to create a global gene-expression profile from microarray data. Genome Biol. 2003, 4(1):R7.
25. Hosack D.A. Identifying biological themes within lists of genes with EASE. Genome Biol. 2003, 4(10):R70.
26. Irizarry R.A. Summaries of Affymetrix GeneChip probe level data. Nucleic Acids Res. 2003, 31(4):e15.
27. Irizarry R.A. Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics 2003, 4(2):249-264.
28. Irizarry R.A., Wu Z., Jaffee H.A. Comparison of Affymetrix GeneChip expression measures. Bioinformatics 2005, 1(1):1-7.
29. Klimanskaya I. Derivation and comparative assessment of retinal pigment epithelium from human embryonic stem cells using transcriptomics. Cloning Stem Cells 2004, 6(3):217-245.
30. Lai J.Y. Phenotypic and functional characterization of in vivo engineered smooth muscle from normal and pathological bladders. J. Urol. 2002, 168:1853-1857. (4 Pt 2).
31. Li C., Wong W.H. Model-based analysis of oligonucleotide arrays: expression index computation and outlier detection. Proc. Natl Acad. Sci. USA 2001, 98(1):31-36.
32. Linder D., McCaw B.K., Hecht F. Parthenogenic origin of benign ovarian teratomas. New Engl. J. Med. 1975, 292(2):63-66.
33. Lipshutz R.J. High density synthetic oligonucleotide arrays. Nat. Genet. 1999, 21(Suppl 1):20-24.
34. Lockhart D.J. Expression monitoring by hybridization to high-density oligonucleotide arrays. Nat. Biotechnol. 1996, 14(13):1675-1680.
35. Minev B. Cytotoxic T cell immunity against telomerase reverse transcriptase in humans. Proc. Natl Acad. Sci. USA 2000, 97(9):4796-4801.
36. Oberpenning F. De novo of a functional mammalian urinary bladder by tissue engineering. Nat. Biotechnol. 1999, 17(2):149-155.
37. Palmqvist L. Correlation of murine embryonic stem cell gene expression profiles with functional measures of pluripotency. Stem Cells 2005, 23(5):663-680.
38. Pardal R., Clarke M.F., Morrison S.J. Applying the principles of stem-cell biology to cancer. Nat. Rev. Cancer 2003, 3(12):895-902.
39. Parkinson H. ArrayExpress - a public repository for microarray gene expression data at the EBI. Nucleic Acids Res. 2005, 33(Database issue):D553-D555.
40. Perez-Iratxeta C. Study of stem cell function using microarray experiments. FEBS Lett. 2005, 579(8):1795-1801.
41. Saha S. Using the transcriptome to annotate the genome. Nat. Biotechnol. 2002, 20(5):508-512.
42. Sarkans U. The ArrayExpress gene expression database: a software engineering and implementation perspective. Bioinformatics 2005, 21(8):1495-1501.
43. Sato N. Molecular signature of human embryonic stem cells and its comparison with the mouse. Dev. Biol. 2003, 260(2):404-413.
44. Smyth G.K. Linear models and empirical Bayes methods for assessing differential expression in microarray experiments. Stat. Appl. Genet.Molec. Biol. 2004, 3(1).
45. Smyth G.K. Limma: linear models for microarray data. Bioinformatics and Computational Biology Solutions using R and Bioconductor 2005, 397-420.. Springer, New York. R. Gentleman (Ed.).
46. Stein L.D. Human genome: end of the beginning. Nature 2004, 431(7011):915-916.
47. Tripathy D. Safety of treatment of metastatic breast cancer with trastuzumab beyond disease progression. J. Clin. Oncol. 2004, 22(6):1063-1070.
48. Velculescu V.E. Serial analysis of gene expression. Science 1995, 270(5235):484-487.
49. Vogel C.L. First-line herceptin monotherapy in metastatic breast cancer. Oncology 2001, 61(Suppl 2):37-42.
50. Vogel C.L. Efficacy and safety of trastuzumab as a single agent in first-line treatment of HER2-overexpressing metastatic breast cancer. J. Clin. Oncol. 2002, 20(3):719-726.
51. Vrana K.E. Nonhuman primate parthenogenetic stem cells. Proc. Natl. Acad. Sci. USA 2003, 100(Suppl 1):11911-11916.
52. Wettenhall J.M. affylmGUI Package Vignette, Document 2004, 4-6-2004. Ref Type: Generic.
53. Wettenhall J.M., Smyth G.K. limmaGUI: a graphical user interface for linear modeling of microarray data. Bioinformatics 2004, 20(18):3705-3706.
54. Wu Z., Irizarry R.A. Stochastic models inspired by hybridization theory for short oligonucleotide arrays. J. Comput. Biol. 2005, 12(6).